Wilko Single Dose Wormer for Small Dogs and Puppies, 100 mg Film Coated Tablets

Nazione: Regno Unito

Lingua: inglese

Fonte: VMD (Veterinary Medicines Directorate)

Compra

Scarica Scheda tecnica (SPC)
15-08-2019

Principio attivo:

Nitroscanate

Commercializzato da:

Novartis Animal Health UK Ltd

Codice ATC:

QP52AX01

INN (Nome Internazionale):

Nitroscanate

Stato dell'autorizzazione:

Expired

Scheda tecnica

                                Revised: 29 May 2008
AN: 01780/2007
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Wilko Single Dose Wormer for Small Dogs and Puppies, 100mg film coated
tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient
mg/tablet
Nitroscanate
100
For a full list of excipients see section 6.1.
3.
PHARMACEUTICAL FORM
Film coated tablet.
Yellowish-white to light beige round, film coated tablet.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs over 8 weeks old.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Wilko Single Dose Wormer for Small Dogs and Puppies is a broad
spectrum
anthelmintic for use in dogs from 8 weeks of age. It is highly
effective in a
single dose against common canine nematodes and cestodes in the UK,
including _Toxocara canis, Toxascaris leonina, Ancylostoma caninum, _
_Uncinaria stenocephala, Taenia ovis, Taenia hydatigena, Taenia
pisiformis _
and_ Dipylidium caninum._
At the recommended dosage, the product gives limited control of
_Echinococcus granulosus._
4.3
CONTRAINDICATIONS
Do not administer if your dog is sick or recovering from an illness.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: 29 May 2008
AN: 01780/2007
4.5
SPECIAL PRECAUTIONS FOR USE
I)
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not repeat treatment if vomiting occurs shortly after dosing.
II)
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
MEDICINAL PRODUCT TO ANIMALS
Tablets are film coated and should not be broken or divided.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
The tablets, when administered as recommended are unlikely to cause
vomiting. See section 4.5 i).
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not contraindicated in pregnant animals. Nursing females should be
treated at
the same time and as frequently as puppies up to 12 weeks of age.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNT(S) TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For the routine treatment of puppies and adult dogs, the 
                                
                                Leggi il documento completo
                                
                            

Cerca alert relativi a questo prodotto